NAYA
Income statement / Annual
Last year (2023), NAYA Biosciences, Inc.'s total revenue was $3.02 M,
an increase of 267.38% from the previous year.
In 2023, NAYA Biosciences, Inc.'s net income was -$8.03 M.
See NAYA Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2010
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2010 |
| Operating Revenue |
$3.02 M |
$822,196.00 |
$4.16 M |
$1.04 M |
$1.48 M |
$494,375.00 |
$282,145.00 |
$50,901.00 |
$11,689.00 |
$67,648.00 |
| Cost of Revenue |
$1.93 M
|
$850,770.00
|
$145,052.00
|
$88,760.00
|
$139,670.00
|
$90,367.00
|
$51,954.00
|
$15,094.00
|
$7,810.00
|
$21,828.00
|
| Gross Profit |
$1.09 M
|
-$28,574.00
|
$4.02 M
|
$948,526.00
|
$1.34 M
|
$404,008.00
|
$230,191.00
|
$35,807.00
|
$3,879.00
|
$45,820.00
|
| Gross Profit Ratio |
0.36
|
-0.03
|
0.97
|
0.91
|
0.91
|
0.82
|
0.82
|
0.7
|
0.33
|
0.68
|
| Research and Development Expenses |
$165,945.00
|
$544,043.00
|
$216,430.00
|
$398,426.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.49 M
|
$9.98 M
|
$9.02 M
|
$6.07 M
|
$3.13 M
|
$3.04 M
|
$870,612.00
|
$2.15 M
|
$598,953.00
|
$1.56 M
|
| Other Expenses |
$200,894.00
|
$77,301.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$7.65 M
|
$10.60 M
|
$9.23 M
|
$6.46 M
|
$3.13 M
|
$3.04 M
|
$870,612.00
|
$2.15 M
|
$598,953.00
|
$1.56 M
|
| Cost And Expenses |
$9.79 M
|
$11.45 M
|
$9.38 M
|
$6.55 M
|
-$3.27 M
|
-$3.13 M
|
-$922,566.00
|
-$2.16 M
|
-$606,763.00
|
-$1.58 M
|
| Interest Income |
$0.00
|
$308.00
|
$3,657.00
|
$4,190.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$925,909.00
|
$59,445.00
|
$1.27 M
|
$2.84 M
|
$379,019.00
|
$442,031.00
|
$20,873.00
|
$13,838.00
|
$32,017.00
|
$463,001.00
|
| Depreciation & Amortization |
$200,894.00
|
$77,301.00
|
$166,082.00
|
$34,481.00
|
$25,346.00
|
$5,190.00
|
$2,810.00
|
$1,878.00
|
$5,633.00
|
$14,042.00
|
| EBITDA |
-$6.88 M |
-$10.75 M |
-$5.22 M |
-$5.48 M |
-$1.76 M |
-$2.63 M |
-$678,480.00 |
-$2.11 M |
-$4.92 M |
$323,613.00 |
| EBITDA Ratio |
-2.28
|
-13.08
|
-1.25
|
-5.28
|
-1.19
|
-5.32
|
-2.4
|
-41.42
|
-421.05
|
4.78
|
| Operating Income Ratio |
-2.24
|
-12.92
|
-1.25
|
-5.32
|
-1.21
|
-5.33
|
-2.27
|
-41.46
|
-50.91
|
-22.4
|
| Total Other Income/Expenses Net |
-$1.24 M
|
-$263,158.00
|
-$1.43 M
|
-$2.83 M
|
-$379,019.00
|
-$442,031.00
|
-$61,742.00
|
-$13,838.00
|
-$4.36 M
|
$1.36 M
|
| Income Before Tax |
-$8.01 M
|
-$10.89 M
|
-$6.65 M
|
-$8.35 M
|
-$2.17 M
|
-$3.08 M
|
-$702,163.00
|
-$2.12 M
|
-$4.96 M
|
-$153,430.00
|
| Income Before Tax Ratio |
-2.65
|
-13.24
|
-1.6
|
-8.05
|
-1.46
|
-6.22
|
-2.49
|
-41.73
|
-424.27
|
-2.27
|
| Income Tax Expense |
$27,786.00
|
$2,872.00
|
$4,764.00
|
$36.00
|
$433.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$8.03 M
|
-$10.89 M
|
-$6.65 M
|
-$8.35 M
|
-$2.17 M
|
-$3.08 M
|
-$702,163.00
|
-$2.12 M
|
-$4.96 M
|
-$153,430.00
|
| Net Income Ratio |
-2.66
|
-13.25
|
-1.6
|
-8.05
|
-1.46
|
-6.22
|
-2.49
|
-41.73
|
-424.27
|
-2.27
|
| EPS |
-5.1308 |
-8.9853 |
-6.2591 |
-15.2053 |
-4.464 |
-6.6816 |
-1.5904 |
-6.4 |
-12.8 |
-0.64 |
| EPS Diluted |
-5.1308 |
-8.9853 |
-6.2591 |
-15.2053 |
-4.464 |
-6.6816 |
-1.5904 |
-6.4 |
-12.8 |
-7.68 |
| Weighted Average Shares Out |
$3.13 M
|
$2.42 M
|
$2.13 M
|
$1.10 M
|
$970,972.00
|
$920,828.00
|
$883,156.00
|
$869,912.00
|
$803,544.00
|
$396,876.00
|
| Weighted Average Shares Out Diluted |
$3.13 M
|
$2.42 M
|
$2.13 M
|
$1.10 M
|
$970,972.00
|
$920,828.00
|
$883,156.00
|
$869,912.00
|
$803,544.00
|
$396,876.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
